Oncode Accelerator

Curated by Signal

Developer of new cancer therapies

Overview

Developer of new cancer therapies. It aims to address unmet medical needs in cancer treatment by revolutionizing the preclinical development process, with emphasis on enhancing patient outcomes. It providing an AI platform to create and validate AI tools that will be integrated throughout the preclinical development process.

Key facts

Founded: 2023
Headquarters: Utrecht, Netherlands
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CycleMasters
Provider of indoor cycling workouts at home
Health TechnologyBleiswijk, Netherlands
Maternify
Online platform providing digital support and resources for pregnant women and mothers
Health TechnologyAmsterdam, Netherlands
Healsens
Provider of AI-based practice management software for healthcare providers
Health TechnologyAmsterdam, Netherlands

About Oncode Accelerator

What does Oncode Accelerator do?

Developer of new cancer therapies.

Where is Oncode Accelerator headquartered?

Oncode Accelerator is headquartered in Utrecht, Netherlands.

When was Oncode Accelerator founded?

Oncode Accelerator was founded in 2023.

Which sector is Oncode Accelerator in?

Oncode Accelerator operates in Health Technology.

Who are Oncode Accelerator's competitors?

Companies similar to Oncode Accelerator include CycleMasters, Maternify, and Healsens.